Adelaide Research & Scholarship: Search

Search

Results 1-10 of 24 (Search time: 0.004 seconds).

previous
1
2
3
next

Item hits:

Preview	Issue Date	Title	Author(s)
	2006	Suppression of androgen receptor signaling in prostate cancer cells by an inhibitory receptor variant	Butler, L.; Centenera, M.; Neufing, P.; Buchanan, G.; Choong, C.; Ricciardelli, C.; Saint, K.; Lee, M.; Ochnik, A.; Yang, M.; Brown, M.; Tilley, W.
	2011	Stimulating healthy tissue regeneration by targeting the 5-HT₂B receptor in chronic liver disease	Ebrahimkhani, M.; Oakley, F.; Murphy, L.; Mann, J.; Moles, A.; Perugorria, M.; Ellis, E.; Lakey, A.; Burt, A.; Douglass, A.; Wright, M.; White, S.; Jaffre, F.; Maroteaux, L.; Mann, D.
	2017	Leptin signals via TGFB1 to promote metastatic potential and stemness in breast cancer	Mishra, A.; Parish, C.; Wong, M.; Licinio, J.; Blackburn, A.; Ahmad, A.
	2020	CMTM8 is a suppressor of human mesenchymal stem cell osteogenic differentiation and promoter of proliferation via EGFR signalling	H'ng, C.H.; Camp, E.; Anderson, P.J.; Zannettino, A.C.W.; Gronthos, S.
	2020	Stathmin levels alter PTPN14 expression and impact neuroblastoma cell migration	Po uha, S.T.; Le Grand, M.; Brandl, M.B.; Gifford, A.J.; Goodall, G.J.; Khew-Goodall, Y.; Kavallaris, M.
	2021	The BMP antagonist Gremlin1 contributes to the development of cortical excitatory neurons, motor balance and fear responses	Suzuki, M.; Suzuki, N.; Wang, T.; Kobayashi, H.; Vrbanac, L.; Ng, J.Q.; Wright, J.A.; Lannagan, T.R.M.; Gieniec, K.A.; Lewis, M.; Ando, R.; Enomoto, A.; Koblar, S.; Thomas, P.; Worthley, D.L.; Woods, S.L.
	2018	Deregulation of kinase signaling and lymphoid development in EBF1-PDGFRB ALL leukemogenesis	Welsh, S.; Churchman, M.; Togni, M.; Mullighan, C.; Hagman, J.
	2014	Gemcitabine and CHK1 inhibition potentiate EGFR-directed radioimmunotherapy against pancreatic ductal adenocarcinoma	Al-Ejeh, F.; Pajic, M.; Shi, W.; Kalimutho, M.; Miranda, M.; Nagrial, A.; Chou, A.; Biankin, A.; Grimmond, S.; Brown, M.; Khanna, K.
	2023	Distinct Assemblies of Heterodimeric Cytokine Receptors Govern Stemness Programs in Leukemia	Kan, W.L.; Dhagat, U.; Hercus, T.R.; Kaufmann, K.B.; Nero, T.L.; Zeng, A.G.X.; Toubia, J.; Barry, E.F.; Broughton, S.E.; Gomez, G.A.; Dottore, M.; Cheung Tung Shing, K.S.; Thomas, D.; Benard, B.; Simpson, K.J.; Schoof, E.; Goodall, G.J.; Begley, C.G.; Ekert, P.G.; Tvorogov, D.; et al.
	2018	Accumulation of JAK activation loop phosphorylation is linked to type I JAK inhibitor withdrawal syndrome in myelofibrosis	Tvorogov, D.; Thomas, D.; Liau, N.P.D.; Dottore, M.; Barry, E.F.; Lathi, M.; Kan, W.L.; Hercus, T.R.; Stomski, F.; Hughes, T.P.; Tergaonkar, V.; Parker, M.W.; Ross, D.M.; Majeti, R.; Babon, J.J.; Lopez, A.F.